Results 41 to 50 of about 26,585 (198)

Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I

Acta Dermato-Venereologica, 2018
The development of androgenetic alopecia is associated with a risk of developing cardiovascular diseases, but the association of alopecia areata with cardiovascular diseases in humans is largely unexplored.
Eddy Hsi Wang, Leopoldo Santos, Xi Yuan Li, Annie Tran, Sandra S.Y. Kim, Katrina Woo, Jerry Shapiro, Kevin J. McElwee   +7 more
doaj   +1 more source

Changes in the hair growth cycle in women with non-scarring alopecia

Vestnik Dermatologii i Venerologii, 2019
One of the key elements in the pathophysiological process of androgenetic alopecia and telogen hair loss is the change of hair cycle. Growth factors controlling the development and cycle of the hair follicle have thus far been established.
A. A. Kubanov, Y. A. Gallyamova, O. A. Korableva   +2 more
doaj   +1 more source

Oral Minoxidil for Androgenetic Alopecia

, 2022
Purpose: The purpose of this article is to review the current treatment options of androgenetic alopecia and to explore the risk and potential benefits of oral Minoxidil therapy.
Ingram, Laurice D
core   +1 more source

Psychosocial aspects of androgenetic alopecia [PDF]

, 1992
The main objective of the studies described in this thesis is to study the psychosocial problems of men and women with androgenetic alopecia who applied for treatment.
Donk, A. (Jos) van der
core   +1 more source

Androgenetic alopecia: An update

Indian Journal of Dermatology, Venereology, and Leprology, 2013
Androgenetic alopecia (AGA) is one of the commonest reasons for dermatological consultation. Over the last few years our understanding of the pathophysiology of AGA has improved and this has paved way for better diagnostic and therapeutic options.
Feroze, Kaliyadan, Ajit, Nambiar, Sundeep, Vijayaraghavan   +2 more
openaire   +2 more sources

Androgenetic Alopecia in Women [PDF]

Journal of Investigative Dermatology Symposium Proceedings, 2003
Androgenetic alopecia (AGA), also known in women as female pattern hair loss, is caused by androgens in genetically susceptible women and men. The thinning begins between ages 12 and 40 years, the inheritance pattern is polygenic, and the incidence is the same as in men. In susceptible hair follicles, dihydrotestosterone binds to the androgen receptor,
openaire   +2 more sources

Association of Male Androgenetic Alopecia with Psychosocial and Sexual Well-being in Early Middle-aged Men: A Northern Finland Birth Cohort 1986 Study

Acta Dermato-Venereologica
Androgenetic alopecia is the most common type of hair loss in men. It is reported to have a strong effect on the quality of life, especially at a young age.
Arttu Järvinen, Jari Jokelainen, Laura Huilaja, Suvi-Päivikki Sinikumpu   +3 more
doaj   +1 more source

EDA2R Is Associated with Androgenetic Alopecia [PDF]

Journal of Investigative Dermatology, 2008
Androgenetic alopecia (AGA) is a common heritable polygenic disorder whose genetics is not fully understood, even though it seems to be X-linked. We carried out an epidemiological survey for AGA on 9,000 people from 8 isolated villages of a secluded region of Sardinia (Ogliastra), and identified a large cohort of affected individuals.
Prodi DA, Pirastu N, Maninchedda G, Sassu A, Picciau A, Palmas MA, Mossa A, Persico I, Adamo M, Angius A, Pirastu M   +10 more
openaire   +6 more sources

Two different trichoscopic patterns of mid-frontal scalp in patients with frontal fibrosing alopecia and clinical features of androgenetic alopecia

, 2017
Introduction . Frontal fibrosing alopecia is a primary lymphocytic cicatricial alopecia with progressive frontotemporal hairline recession. In some cases, hair loss in the mid-frontal scalp, similar to female pattern hair loss, may be observed ...
Anna Waśkiel, Adriana Rakowska, Małgorzata Olszewska, Lidia Rudnicka, Mariusz Sikora   +4 more
core   +1 more source

Artificial intelligence empowers targeted protein degradation: Core technological innovations, multi‐scenario applications, and translational prospects

Smart Molecules, EarlyView.
AI is transforming TPD by improving the design, prediction, and optimization of degraders such as PROTACs, molecular glues, and LYTACs. This review summarizes key AI‐driven advances, highlights applications across drug discovery stages, and discusses remaining challenges and future directions for accelerating the development of therapies against ...
Shuanglin Qin, Rui Peng, Guangshuai Zhang, Si Yan, Jin Xiao, Zishu Liu, Ziyu Tan, Qingqing Xie, Shangjie Li, Wei Luo, Xiaohe Xiao   +10 more
wiley   +1 more source